Stakeholders discuss next steps after WHO advises against use of remdesivir for COVID-19 treatment Question if there is an alternative currently to the drug for the treatment of moderate to severe COVID-19 patients
Mylan commercially launches Remdesivir under brand name DESREM in India Mylan received license from Gilead for commercialisation of Remdesivir
